Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by made2laston Jul 08, 2017 1:27pm

127 Views

Post# 26447321

RE:RE:RE:They could even wait till CT scan of 1st high dose patients

Hi LaserStock29;

I like your NR solution. It's should be abundently clear that a statement addressing the normal course of action for bladder cancer at this stage requires a certain action, and by inferance, the situation may have been altered by Theralase intervention.

The question is, will the controlling parties ever allow such a simple observation? This feels like a hostage situation where the hostage tries blinking or finger movement to signal the situation.

Thanks;

made2last

Bullboard Posts

Another EV stock bites the dust